N-acetyl-L-cysteine Amide Protects Retinal Pigment Epithelium Against Methamphetamine-induced Oxidative Stress by Ercal, Nuran et al.
Missouri University of Science and Technology 
Scholars' Mine 
Chemistry Faculty Research & Creative Works Chemistry 
01 Jan 2012 
N-acetyl-L-cysteine Amide Protects Retinal Pigment Epithelium 
Against Methamphetamine-induced Oxidative Stress 
Nuran Ercal 
Missouri University of Science and Technology, nercal@mst.edu 
Joshua W. Carey 
Shakila Tobwala 
Xinsheng Zhang 
et. al. For a complete list of authors, see https://scholarsmine.mst.edu/chem_facwork/410 
Follow this and additional works at: https://scholarsmine.mst.edu/chem_facwork 
 Part of the Chemistry Commons 
Recommended Citation 
N. Ercal et al., "N-acetyl-L-cysteine Amide Protects Retinal Pigment Epithelium Against 
Methamphetamine-induced Oxidative Stress," Journal of Biophysical Chemistry, Scientific Research 
Publishing, Jan 2012. 
The definitive version is available at https://doi.org/10.4236/jbpc.2012.32012 
This Article - Journal is brought to you for free and open access by Scholars' Mine. It has been accepted for 
inclusion in Chemistry Faculty Research & Creative Works by an authorized administrator of Scholars' Mine. This 
work is protected by U. S. Copyright Law. Unauthorized use including reproduction for redistribution requires the 
permission of the copyright holder. For more information, please contact scholarsmine@mst.edu. 
Vol.3, No.2, 101-110 (2012)                                                  Journal of Biophysical Chemistry 
http://dx.doi.org/10.4236/jbpc.2012.32012  
N-acetyl-L-cysteine amide protects retinal pigment 
epithelium against methamphetamine-induced  
oxidative stress 
Joshua W. Carey1, Shakila Tobwala1, Xinsheng Zhang1, Atrayee Banerjee1, Nuran Ercal1*, 
Eylem Y. Pinarci2, Humeyra Karacal3 
 
1Department of Chemistry, Missouri University of Science & Technology, Rolla, USA; *Corresponding Author: nercal@mst.edu 
2Department of Ophthalmology, Baskent University School of Medicine, Ankara, Turkey 
3Department of Ophthalmology, Washington University in St. Louis, St. Louis, USA 
 
Received 22 March 2012; revised 9 April 2012; accepted 20 April 2012 
ABSTRACT 
Methamphetamine (METH), a highly addictive 
drug used worldwide, induces oxidative stress 
in various animal organs. Recent animal studies 
indicate that methamphetamine also induces 
oxidative stress in the retina, which is an em- 
bryonic extension of the forebrain. The aim of 
this study, therefore, was to evaluate the pro- 
tecttive effects of N-acetylcysteine amide (NACA) 
against oxidative stress induced by METH in 
retinal pigment epithelium (RPE) cells. Our stud- 
ies showed that NACA protected against METH- 
induced oxidative stress in retinal pigment 
epithelial cells. Although METH significantly de- 
creased glutathione (GSH) levels and increased 
reactive oxygen species (ROS) and malondial- 
dehyde (MDA) levels, these returned to control 
levels with NACA treatment. Overall observa- 
tions indicated that NACA protected RPE cells 
against oxidative cell damage and death by in- 
hibiting lipid peroxidation, scavenging ROS, in- 
creasing levels of intracellular GSH, and main- 
taining the antioxidant enzyme activity and the 
integrity of the bloodretinal barrier (BRB). The 
effectiveness of NACA should be further evalu- 
ated to determine its potential for the treatment 
of numerous retinal diseases caused by oxida- 
tive stress. 
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1. INTRODUCTION 
Methamphetamine (METH), a highly addictive psy- 
chostimulant, is abused by approximately 35 million people 
worldwide [1]. A dramatic increase in METH-related 
emergency department visits is alarming, with >50% 
involving young adults between the ages of 18 - 34 years 
[2]. The relative ease of METH’s availability, coupled 
with its toxicity, has resulted in increased numbers of 
associated medical complications and fatalities [2,3]. 
Oxidative stress is believed to play a crucial role in 
METH-induced toxicity and is supported by several 
studies which reported decreased glutathione (GSH) levels, 
reduced levels and activities of antioxidant enzymes, and 
increased lipid peroxidation and protein carbonylation, 
all hallmarks of oxidative stress [4-8]. In the case of the 
brain, it is believed that, initially, METH causes a mas-
sive release of dopamine by inhibiting monoamine oxi-
dase activity and dopamine uptake [9]. With higher doses, 
however, it causes dopamine depletion by degenerating 
dopaminergic terminals, damaging dopaminergic neurons, 
and decreasing dopamine transporter numbers [10,11]. 
Dopamine then reacts with molecular oxygen to form 
reactive oxygen species (ROS), such as hydrogen perox-
ide, superoxide, and hydroxyl free radicals, resulting in a 
condition known as oxidative stress [11] and causes 
neuronal death by apoptosis [12]. 
Oxidative stress acts as a propagating force in the 
pathogenesis of many ocular disorders, including cata- 
racts, glaucoma, diabetic retinopathy, HIV-related reti- 
nopathy, and age-related macular degeneration (AMD) 
[13-15]. Oxidative stress possibly contributes to the death of 
retinal cells and degeneration of the macula [16-20]. Free 
radical formation in a developing retina has been re- 
ported to be induced by xenobiotics, e.g., environmental 
pollutants, pharmacological substances, and alcohol [21]. 
METH abuse is implicated in a number of serious 
ocular pathologies, including corneal ulceration, retinal 
vasculitis, episcleritis, scleritis, panophthalmitis, endoph- 
thalmitis, and retinopathy [22-24]. It has been reported 
that METH induces oxidative stress in the retina and 
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adversely affects the dopaminergic system of the rat retina 
[25], particularly during central nervous system (CNS) 
development. Prudencio et al. [26] demonstrated that 
METH altered retinal plasma membrane integrity, este- 
rase activity, and/or pH in rat retina homogenates. An- 
other study reported exacerbation of damaging effects of 
kainic acid on the retina by METH [27]. Under physio- 
logical conditions, high levels of antioxidant enzymes 
and small antioxidant molecules, particularly glutathione 
(GSH), in the Muller (glial) cells protects retinal pigment 
epithelium (RPE) cells against oxidative stress. GSH in 
the Muller cells is depleted under oxidative stress and, 
since GSH cannot be transported directly into the cells, 
the need arises for permeable compounds that can increase 
intracellular GSH levels. One such compound, known to 
increase intracellular GSH levels in cells, is the low mo- 
lecular weight thiol antioxidant, N-acetylcysteine amide 
(NACA). Previous work by our group has demonstrated 
that NACA restored the levels of GSH, and scavenged 
the ROS produced in human brain endothelial cells, upon 
treatment with METH [4]. 
Even though the adverse effects of METH on the brain 
are linked to oxidative stress, little is known about its 
effect on the retina. Considering the ability of NACA to 
protect cells from oxidative stress [28-30], the effective- 
ness of this antioxidant was evaluated as a treatment op- 
tion for METH-induced oxidative damage to RPE cells. 
Understanding NACA’s protective role against METH- 
induced oxidative damage to RPE cells would help de- 
velop NACA as a potential therapeutic agent for treating 
RPE cells against numerous oxidative stress-related ocular 
diseases. 
2. MATERIALS AND METHODS 
2.1. Materials 
The retinal pigment epithelial cell line, ARPE-19, was 
purchased from the American Type Culture Collection 
(ATCC # CRL-2302) (Manassas, VA), and the N-acety- 
lcysteine amide (NACA) from Dr. Glenn Goldstein of 
David Pharmaceuticals in New York, NY. HPLC chemicals 
were obtained from Fisher Scientific (Pittsburgh, PA). 
Cell culture reagents were purchased from ATCC in Ma- 
nassas, VA, and Calcein AM was bought from Biotium, Inc. 
(Hayward, CA). The National Institute on Drug Abuse 
(NIDA) provided methamphetamine, while other chemi- 
cals were obtained from Sigma-Aldrich (St. Louis, MO), 
unless otherwise stated. 
2.2. ARPE-19 Cell Culture and Treatment 
The ARPE-19 cells were cultured in a one-to-one ratio 
of DMEM: F-12 culture medium, and supplemented with 
10% (v/v) FBS, 100 U/mL of penicillin, and 100 μg/mL 
of streptomycin. Cells were maintained in a 37˚C incubator 
and supplied with 95% air and 5% CO2. Cells between 
passage numbers 26 and 32 were used for experiments. 
2.3. Determination of Cell Viability 
The ARPE-19 cells were seeded in a 96-well tissue 
culture plate, at a density of approximately 1.25 × 104 
cells/well, for a day. The media was then discarded and 
the cells were treated with various concentrations of METH 
and NACA in serum-free media for 24 hours and 2 hours, 
respectively. Protective effects of NACA were studied by 
pre-incubating cells with NACA for 2 hours, followed by 
treatment with 500 µM of METH for 24 hours. After 24 
hours of METH treatment, the medium was discarded 
and a Calcein AM assay KIT (Biotium, Inc. CA) was 
used to determine cell viability relative to the control 
group [31]. The cells were then washed three times with 
PBS, and 100 µL of 2.0 M Calcein AM in PBS were 
added to each well for 30 minutes at 37˚C. The fluores- 
cence was measured with an excitation wavelength at 
485 nm and an emission wavelength of 530 nm, using a 
microplate reader (FLUOstar, BMG Labtechnologies, 
Durham, NC, USA). 
2.4. Intracellular ROS Measurement 
Intracellular ROS generation was measured using a 
well-characterized probe, 2’, 7’-dichlorofluorescin diace- 
tate (DCFH-DA) [32]. ARPE-19 cells were seeded at a 
density of 1.25 × 104 cells/well in a 96-well plate. 
DCFH-DA is hydrolyzed by esterases to dichlorofluo- 
rescin (DCFH), which was trapped within the cell. This 
nonfluorescent molecule is then oxidized to fluorescent 
dichlorofluorescin (DCF) by the action of cellular oxi- 
dants. In groups with NACA pretreatment, media con- 
taining 1 mM NACA was added and incubated for 2 
hours. Once pretreated, the cells were washed twice with 
PBS and incubated with a solution of 50 μM DCFH-DA 
in phenol red free media for 30 minutes. This was followed 
by washing the cells twice with PBS, and the respective 
groups were then dosed either with 500 µM METH or 
plain media for 4 hours and then fluorescence was deter- 
mined at 485 nm excitation and 520 nm emission, using 
a microplate reader (FLUOstar, BMG Labtechnologies, 
Durham, NC, USA). 
2.5. Experimental Design for Oxidative 
Stress Parameters 
Parameters, including GSH, MDA, and activities of 
glutathione peroxidase and catalase, were measured after 
the cells were treated, as described below. After seeding 
the cells, the flasks were divided into the following four 
groups: 1) control; 2) NACA-only; 3) METH-only; and 4) 
METH + NACA. In groups with NACA pretreatment, 
media containing 1 mM NACA was added and incubated 
Copyright © 2012 SciRes.                                                                    OPEN ACCESS 
J. W. Carey et al. / Journal of Biophysical Chemistry 3 (2012) 101-110 103
for 2 hours. After pretreatment, the media in the control 
and NACA-only groups were replaced with plain media, 
while both of the remaining two groups received media 
containing METH for 24 hours. The cell pellets obtained 
were then further processed for appropriate assays. 
2.5.1. Determination of Glutathione (GSH) 
The levels of GSH in the tissues were determined by 
RP-HPLC, according to the method developed in our 
laboratory [33]. The HPLC system (Thermo Electron Cor- 
poration) consisted of a Finnigan Spectra System vacuum 
membrane degasser (model SCM1000), a gradient pump 
(model P2000), autosampler (model AS3000), and a 
fluorescence detector (model FL3000) with ex = 330 nm 
and em = 376 nm. The HPLC column used was a 
Reliasil ODS-1 C18 column (5 µm packing material) 
with 250 mm × 4.6 mm i.d. (Column Engineering, 
Ontario, CA). The mobile phase (70% acetonitrile and 
30% water) was adjusted to a pH of 2 with acetic acid and 
o-phosphoric acid. The N-(1-pyrenyl)-maleimide (NPM) 
derivatives of GSH were eluted from the column iso- 
cratically at a flow rate of 1 mL/min. The cell samples 
were homogenized in a serine borate buffer (100 mM 
Tris HCl, 10 mM borate, 5 mM serine, 1 mM diethylene- 
triaminepentaacetic acid), centrifuged, and 50 µL of the 
supernatant were added to 230 µL of HPLC grade water 
and 750 µL of NPM (1 mM in acetonitrile). The resulting 
solution was incubated at room temperature for 5 minutes, 
and the reaction was stopped by adding 10 µL of 2 N 
HCl. The samples were then filtered through a 0.45 µm 
filter and injected into the HPLC system. 
2.5.2. Determination of Malondialdehyde (MDA) 
The MDA levels were determined according to the 
method described by Draper et al. [34]. Briefly, 550 µL 
of 5% tricholoroacetic acid (TCA) and 100 µL of 500 
ppm butylated hydroxytoluene (BHT) in methanol were 
added to 350 µL of the cell homogenates, and boiled for 
30 minutes in a water bath. After cooling on ice, the mix- 
tures were centrifuged, and the supernatant collected was 
mixed 1:1 with saturated thiobarbituric acid (TBA). The 
mixture was again heated in a water bath for 30 minutes, 
followed by cooling on ice. 500 µL of the mixture was 
extracted with 1 mL of nbutanol and centrifuged to faci- 
litate the separation of phases. The resulting organic 
layers were first filtered through 0.45 µm filters and then 
injected into the HPLC system (Shimadzu, US), which 
consisted of a pump (model LC-6A), a Rheodyne injection 
valve and a fluorescence detector (model RF 535). The 
column was a 100 mm × 4.6 mm i.d. C18 column (3 µm 
packing material, Astec, Bellefonte, PA). The mobile 
phase used contained 69.4% sodium phosphate buffer, 
30% acetonitrile, and 0.6% tetrahydrofuran. The fluores- 
cent product was monitored at ex = 515 nm and em = 550 
nm. The concentrations of the TBA-MDA complex in the 
mixture was determined by using the calibration curve 
obtained from a 1,1,3,3,-tetraethoxypropane standard so- 
lution. This method differs from commonly used TBARS 
assay in that it specifically determines TBA-MDA adducts 
by HPLC. 
2.5.3. Measurement of Catalase (CAT) Activity  
Catalase activity was measured according to the method 
described by Aebi [35]. Briefly, it was measured spectro- 
photometrically at a wavelength of 240 nm, in the super- 
natant of the cell homogenate, following the exponential 
disappearance of hydrogen peroxide (H2O2, 10 mM). The 
catalase activity was calculated from the equation A60 = 
Ainitiale–kt, where k represents the rate constant, Ainitial is 
the initial absorbance and A60 is the absorbance after 60 
seconds have passed. 
2.5.4. Measurement of Glutathione Peroxidase 
Activity 
Glutathione peroxidase (GPx) activity was determined 
using a glutathione peroxidase colorimetric assay kit pur- 
chased from Oxis Research (Foster City, CA). The cell 
samples were homogenized in 50 mM of phosphate 
buffer (pH 7.4), containing 1.0 mM EDTA, and then 
centrifuged at 7500 × g for 10 minutes. The resulting 
supernatant was collected to be used for the assay while 
the remaining debris was discarded. In brief, the assay 
buffer, supernatant, and NADPH reagent (containing 
glutathione reductase, GSH, and NADPH) were placed 
in a cuvette and the reaction initiated by the addition of 
t-butylhydroperoxide (tBHP). The decrease in absorbance at 
340 nm was recorded for 3 minutes and the change in 
A340/min from the initial linear portion of the curve was 
used to calculate the GPx enzyme activity. The GPx 
activity was calculated using the extinction coefficient of 
NADPH (6220 M–1·cm–1) and expressed as U/mg of 
protein. 
2.5.5. Dextran Permeability Study and 
Trans-Endothelial Electrical Resistance 
(TEER) Measurement 
ARPE-19 cells were seeded at a density of 1.5 × 105 
cells/well onto collagen-coated inserts with a pore size of 
0.4 µm and allowed to form a monolayer. Trans-endo- 
thelial electric resistance (TEER) measurement by an 
EVOM voltohmmeter (World Precision Instrument, 
Sarasota, FL, USA) assessed the tightness of the ARPE 
monolayer [4]. The cell monolayer was then treated as 
described in Experimental Design. After this, the media 
was replaced with 150 µL of fresh medium. The insert 
containing the cell monolayer was then transferred to a 
fresh plate containing 500 µL of serum-free medium. The 
TEER reading was recorded immediately and TEER 
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values were calculated as: Resistance × 0.32 cm2 (insert 
surface area). Thus, resistance is proportional to the effe- 
ctive membrane. 
2.6. Determination of Protein 
Protein levels of the cell samples were measured by 
the Bradford method [36] using bovine serum albumin as 
standard. 
2.7. Statistical Analysis 
Statistical significance was calculated using an unpaired 
two-tailed student’s t test in which “*” represents a 
p-value ≤ 0.05 when compared to the control group, and 
“**” represents a p-value ≤ 0.05 when compared to the 
METH group. All reported values were represented as 
mean ± S.D. of triplets. 
3. RESULTS 
3.1. Protection from METH Toxicity 
Cell viability was measured as a function of METH 
and NACA dose to determine the optimum concentra- 
tions for both METH and NACA, respectively. Figures 
1(a) and (b) revealed that a concentration of 500 µM 
METH and 1 mM NACA are the minimum toxic doses 
of METH and NACA, for ARPE-19 cells and, therefore, 
these doses were selected for further experiments. Figure 
2 shows that pretreatment with 1.0 mM of NACA suc- 
cessfully protected the ARPE-19 cells from METH- 
induced death, thereby increasing viability to ~92% of 
that of control levels. 
3.2. Intracellular ROS Measurements 
After treatment with 500 µM of METH, ROS production 
was found to have increased. METH (500 µM) induced 
an increase in the DCF fluorescence by approximately 
30%, as compared to that of the control (Figure 3), while 
pretreatment with 1 mM NACA (2 hours prior to exposure) 
completely erased this increase. NACA alone did not 
significantly alter DCF fluorescence compared to that of 
the control. 
3.3. Intracellular Glutathione 
Figure 4 shows the effect of METH on cellular GSH 
levels in ARPE-19 cells in the presence and absence of 
NACA. A 24-hour exposure to METH resulted in an 
increase in cellular oxidative stress. Treatment with 500 
µM of METH altered the GSH level to 80% of that of the 
control. A 500 µM treatment of METH, with a 1 mM 
pretreatment of NACA, was significantly different from 
that of the METH group alone, with p ≤ 0.05 and a GSH 





Figure 1. Cell viability of ARPE-19 cells. (a) Cell 
viability after varying treatments with METH for 
24 hours. A concentration of 500 µM was found to 
be the minimum toxic dose of METH for ARPE- 
19 cells and was used as the optimum dose for all 
experiments. Values are represented as mean ± 
S.D. (*) refers to significant differences from the 
control with p ≤ 0.05. The graph is representative 
of at least three independent experiments; (b) Cell 
viability of ARPE-19 cells after treatment with 
NACA for 2 hours. ARPE-19 cells were treated 
with various concentrations of NACA (0.5 mM, 1 
mM, and 2 mM). After 2 hours of treatment, cell 
viability was quantified by a Calcein AM assay 
and a concentration of 1 mM NACA was used for 
the rest of the experiments in this study. Values are 
represented as mean ± SD. 
 
NACA alone treated group was found to have no signi- 
ficant changes in the GSH levels, as compared to that of 
the control group. 
3.4. Lipid Peroxidation Byproduct: MDA 
MDA was used as an index of lipid peroxidation. MDA 
levels were determined in ARPE-19 cells pretreated with 
NACA for 2 hours, followed by exposure to METH for  
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Figure 2. Cell viability of ARPE-19 cells after treat-
ment with METH and NACA. Cell viability was 
quantified by a Calcein AM assay 24 hours after ex-
posure to METH, following a 2-hour pretreatment 
with NACA. Treatment with METH (500 µM) alone 
was seen to significantly decrease cell viability. NACA 
(1.0 mM) was seen to protect against some METH- 
induced cell toxicity. *p ≤ 0.05 compared to the con- 
trol group, and **p ≤ 0.05 compared to the corre- 
sponding value of the METH group. 
 
 
Figure 3. ROS levels in ARPE-19 cells after treatment 
with METH and NACA. ROS levels were measured after 
4 hours of treatment for control, NACA, METH, and 
METH + NACA groups. The ROS level in the NACA- 
only group was very similar to that of the control group. 
However, a concentration of 500 µM of METH signify- 
cantly decreased the ROS level (*p ≤ 0.05). Pretreatment 
with 1 mM of NACA returned the ROS level to near that 
of the control level (**p ≤ 0.05). The results are repre- 
sentative of at least three independent experiments. 
 
24 hours. METH-treated cells had significantly higher 
levels (about four fold) of MDA, as compared to those of 
the control (Figure 5). Pretreatment with 1 mM of NACA 
completely reduced this increase, with MDA levels 
becoming nearly the same as those of the control. The 
NACA-only treated group showed no significant difference 
when compared to the control. 
 
Figure 4. Intracellular GSH levels in ARPE-19 
cells after treatment with METH and NACA. GSH 
levels were measured after 24 hours of treatment 
for control, NACA, METH, and METH + NACA 
groups. The GSH level in the NACA-only group 
was similar to that of the control. Exposure to 
METH (500 µM) significantly decreased intracel- 
lular GSH (*p ≤ 0.05). Pretreatment with NACA (1 
mM), 2 hours before the addition of METH, pre- 
vented such a dramatic decrease (**p ≤ 0.05). At 
least three independent experiments were performed. 
 
 
Figure 5. MDA levels in ARPE-19 cells after 
treatment with METH and NACA. It was found 
that after 24 hours the MDA levels significantly 
increased. MDA levels in the NACA-only group 
were very similar to those of the control group; 
therefore, this was not included in the figure. 
METH (500 µM) induced a significant increase in 
the MDA level. Addition of 1 mM of NACA pre- 
treatment decreased lipid peroxidation significantly 
below that of METH alone. Values represent the 
mean ± SD. “*” refers to significant differences 
from the control with p ≤ 0.05 and “**” refers to 
the significant differences from the METH-only 
group. The graph is representative of three inde-
pendent experiments. 
3.5. Catalase and Glutathione Peroxidase 
Activity 
Effects of METH on the enzyme activities of catalase 
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(CAT) and glutathione peroxidase (GPx) were measured 
(Table 1). METH administration markedly decreased the 
levels of GPx and CAT enzyme activities by about 30%, 
as compared to the control group. Pretreatment with 
NACA significantly attenuated this decrease to 10% of 
the control GPx activity level but didn’t alter the CAT 
activity level. In both of these experiments, NACA alone 
did not significantly alter the results from those of the 
control group; all experiments were conducted in trip- 
licate. 
3.6. Dextran Permeability and TEER Assays 
The cell permeability assay and TEER are especially 
important in this study because they simulated the integrity 
of the BRB. Permeability studies showed that treatment 
with 500 µM of METH increased permeability by 
approximately 15%, as compared to that of the control 
(Figure 6(a)), while pretreatment with NACA signifi- 
cantly reduced this permeability to levels similar to that 
of the control group. As in the permeability study, TEER 
results (as shown in Figure 6(b)) also indicate the prote- 
ctive effect of NACA. Exposure to 500 µM resulted in a 
decrease in TEER by about 10%, as compared to that of 
the control, while pretreatment with NACA gave resistance 
values only slightly less than control levels. Treatment 
with NACA alone did not significantly alter TEER, as 
compared to that of the control. All experiments were 
conducted in triplicate. 
4. DISCUSSION 
Retinal pigment epithelial (RPE) cells form a nonrene- 
wable monolayer of specialized cells derived from the 
neuroectoderm and are present at the interface between 
choroidal capillaries and the neurosensory retina. They 
play numerous roles, including regulation of ion and me- 
tabolite transport, phagocytosis of shed photoreceptor 
outer segments, metabolism of retinol, formation of the 
outer blood-retinal barrier, maintenance of the extra- 
cellular matrix, and metabolism of numerous potential 
 
Table 1. Catalase and GPx activity in ARPE-19 cells after 
treatment with Meth and NACA. 
Group CAT (mU/mg protein) 
GPx 
(mU/mg protein) 
Control 19.5 ± 3.1 56.6 ± 9.8 
NACA only 20.1 ± 5.2 59.5 ± 8.4 
Meth only 14.1 ± 0.6* 39.2 ± 1.7* 
Meth + NACA 19.1 ± 7.8 51.0 ± 7.4** 
Values represent the mean ± SD. “*” refers to significant differences from 
the control with p ≤ 0.05 and “**” refers to the significant differences from 






Figure 6. Protective effects of NACA on dex- 
tran permeability or TEER for ARPE-19 cells 
treated with METH. Cells were seeded onto a 
collagen-coated insert with a pore size of 0.4 
μm at a density of 1.5 × 105/well, and allowed 
to culture until a monolayer formed. The cell 
monolayer was then treated with 500 µM of 
METH with or without the 2-hour pretreatment 
using 1 mM of NACA for 24 hours. (a) Signi- 
ficantly higher permeability of dextran across 
the cell monolayer was observed after treatment 
with METH, as compared to the control (*p ≤ 
0.05). Pretreatment with NACA, however, was 
shown to reduce this permeability (**p ≤ 0.05) 
to levels similar to control values; (b) Cells 
treated with only METH resulted in signify- 
cantly decreased TEER values, as compared 
with both control (*p ≤ 0.05) and METH + 
NACA (**p ≤ 0.05) groups. At least three inde- 
pendent experiments were performed for dex- 
tran permeability or TEER assays. 
 
toxins, such as the free radicals and peroxides [37]. Dysfun- 
ction of the retinal pigment epithelium (RPE) is imp- 
licated in many ocular pathologies, including vision loss. 
Oxidative effects of METH on RPE cells have not 
been extensively studied, despite the fact that METH 
abuse is quite prevalent worldwide, due to the euphoria 
produced, its wide availability, and relatively low cost. 
Herein, we report the in vitro effects of METH on human 
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retinal cells (ARPE-19 cell line) and the role of a novel 
thiol antioxidant, N-acetylcysteine amide (NACA), in 
preventing RPE cell death and maintaining RPE redox 
status. 
METH-treated ARPE cells showed a significant increase 
in ROS accumulation, indicating oxidative stress. This 
resulted in depletion of GSH, the key thiol antioxidant, 
leading to disruption of the thiol redox state and, ulti- 
mately, cell death. A possible explanation for a decrease in 
GSH levels is the reduced activity of the enzymes involved 
in GSH synthesis and/or the oxidation of GSH to GSSG 
under oxidative stress. Pretreatment with NACA in- 
creased the GSH levels and cell viability in the METH- 
treated group, indicating that NACA had replenished the 
GSH levels in these cells and prevented oxidative stress- 
induced cell death. These results are also in accordance 
with our previous study on METH-induced toxicity [4]. 
The protective effect of NACA is probably mediated by 
NACA’s ability to increase GSH biosynthesis by reducing 
extracellular cystine to cysteine, and/or by supplying the 
sulfydryl groups that can stimulate GSH biosynthesis, or 
by conversion of GSSG to GSH [38]. 
Lipid peroxidation is thought to play an important role 
in the pathogenesis of age-related macular degeneration, 
and is a consequence of increased levels of ROS in the 
macula [39]. The membranes of outer segments of photo- 
receptors are rich in polyunsaturated fatty acids (PUFAs), 
which are highly susceptible to radical damage and 
peroxidation [40]. Increased levels of lipid peroxidation 
products can also lead to lysosomal dysfunction in the 
RPE [39]. Therefore, MDA, an important lipid peroxi- 
dation by-product, showed a significant increase in the 
levels when measured in ARPE-19 cells treated with 
METH. Lipid peroxidation is a key mechanism by which 
METH and its radicals induce cell death. It has been 
postulated that radicals attack membrane lipids and 
initiate a chain of events leading to lipid peroxidation 
[41,42]. Pretreatment with NACA successfully reversed 
the increase in MDA levels, indicating that NACA can 
protect RPE cells from lipid peroxidation. Preventing 
this is important for improving RPE lysosomal function, 
as highlighted in a study of the effects of N-acetylcy- 
steine on lysosomal volume and metabolism in RPE cells 
loaded with regular or oxidized human and porcine rod 
outer segments [43]. These results are also in line with a 
previously reported increase in MDA levels [25]. Conco- 
mitant reduction of GSH levels (a substrate for gluta- 
thione peroxidase) might have hampered the decompo- 
sition of lipid peroxides in METH-treated animals. NACA 
was able to break lipid peroxidation chain reaction by 
supplying an adequate amount of GSH as a substrate for 
glutathione peroxidase to effectively decompose lipid 
peroxides, thus reducing MDA levels. 
Antioxidant enzymes are involved in the detoxification 
of lethal peroxides inside the cells. A significant redu- 
ction in the activity of GPx and catalase was observed 
after METH treatment. A decrease in GPx activity may 
have been partially due to diminished GSH levels that 
GPx needs as a substrate. We previously reported decreased 
GPx activity, due to METH, in human brain microva- 
scular endothelial cell culture [36]. Our results are also in 
accordance with the previously reported decrease in GPx 
activity after METH administration [44-47]. In contrast, 
the increased GPx activity in rat brains, observed by 
Flora et al. [48] after METH administration, could have 
been due to the enhanced levels of cellular glutathione 
observed in their study. On the other hand, no change in 
GPx activity in rat brains was reported by Moszczynska 
et al. [6] in response to METH. 
A decrease in catalase activity has been reported for 
various tissues undergoing oxidative stress [49]. However, 
an increase in catalase activity in RPE cells, challenged 
with H2O2, has also been reported [50]. On the other 
hand, Melo et al., [51] were unable to find differences in 
the catalase activity in the retinas of METH-treated rats. 
The response of this antioxidant enzyme to oxidative 
agents could be tissue/organ specific and may be ada- 
ptive. So far, it is poorly understood through which me- 
chanisms METH affects the function of catalase. How- 
ever it is thought that the tyrosyl radical in the catalase 
enzyme is involved in the catalytic activity of the enzyme 
[52,53]. Nitration or a reaction of free radicals with this 
tyrosine residue could lead to inactivation of the enzyme. 
Phosphorylation of the tyrosine residue on catalase has 
also been reported and may lead to decreased activity of 
the catalase enzyme [54]. NACA pretreatment main- 
tained GPx and catalase activity in the METH + NACA 
group, possibly due to the scavenging of free radicals by 
NACA and by providing GSH, which is a substrate for 
GPx. 
In the retina, the RPE forms the blood-retinal barrier 
(BRB) by forming tight junctions that control the ex- 
change of nutrients and metabolites between the retina 
and the underlying choriocapillaries. It is thought that 
oxidative stress may induce changes in the BRB, which 
may contribute to the pathogenesis of retinal degene- 
ration. It was, therefore, important to determine if NACA 
could protect the junctional integrity of ARPE-19 cells 
exposed to oxidative stress. NACA prevented a METH- 
induced decrease in TEER which led to protection of 
cellular homeostasis and outer BRB integrity. A similar 
decrease in TEER has been reported in another study, 
where ARPE-19 cells were exposed to hydrogen pero- 
xide [55]. 
5. CONCLUSIONS 
This study demonstrates that METH induces oxidative 
stress in ARPE cells by depleting GSH and that NACA, a 
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GSH prodrug, protected ARPE cells against METH- 
induced oxidative damage, possibly by a variety of me- 
chanisms, including scavenging of ROS; increasing the 
activity of the detoxification enzyme, glutathione peroxi- 
dase (GPx), by providing GSH which is a limiting substrate 
for GPx activity and halting the production of further 
ROS and lipid peroxidation. GSH might also provide 
protection by recycling other key antioxidants like 
vitamin E and vitamin C. 
A logical approach, therefore, to enhancing antio- 
xidant protection, would be the use of pharmacologic 
doses of highly-active antioxidants that can be delivered 
to the sites of damage caused by ROS. Epidemiological 
data supports the beneficial effects of antioxidant supple- 
mentation to decrease these oxidative processes in the 
retina and retinal pigment epithelium [56]. Studies have 
shown protective effects of NACA against radiation- 
induced toxicity, HIV-protein-induced oxidative stress, 
allergic airway disease, pollutant-induced lung disease, 
and lead-induced cell death [29-31,49]. 
The development of a useful antioxidant agent in the 
form of eye drops would significantly improve the seve- 
rity of eye disorders in METH abusers. Our current and 
future work would provide additional momentum for 
research on antioxidant-based approaches to treating de- 
generative eye conditions. Further investigation could 
help determine NACA’s efficacy in METH-abuse treat- 
ment and an evaluation of the histology in METH-treated 
animals would provide additional information on it’s the- 
rapeutic potential. Remarkable protection shown by 
NACA in previous studies indicates that NACA may be 
developed into a potential treatment option in the pre- 
vention or delay of numerous retinal diseases caused by 
oxidative stress, including METH abuse. 
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